PPHM, OWW, DSCO, CRWE, CLNO - CRWESelect.com Stock News! Peregrine Pharmaceuticals, Orbitz Worldwide, Discovery Laboratories, Crown Equity Holdings, Cleantech Transit (Video Included Inside)

FOR IMMEDIATE RELEASE
Las Vegas, Nevada, United States of America (Free-Press-Release.com) December 6, 2011 -- To view video, and read the full article visit URL http://crweselect.com/27653/stock-alerts/pphm-oww-dsco-crwe-clno-crweselectcom-stock-news-peregrine-pharmaceuticals-orbitz-worldwide-discovery-laboratories-crown-equity-holdings-cleantech-transit-video-included-inside/

Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM)

PPHM announced today preliminary results from a randomized Phase II trial showing a 50% improvement in overall tumor response rates (ORR) in non-small cell lung cancer (NSCLC) patients. Patients treated with bavituximab plus carboplatin and paclitaxel currently demonstrate an ORR of 39%, versus 26% in patients treated with carboplatin and paclitaxel alone. This preliminary analysis using RECIST guidelines included all 86 front-line, Stage IV NSCLC patients randomized in this Phase II trial.

PPHM is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing multiple clinical programs in cancer and hepatitis C virus infection with its lead product candidate bavituximab and novel brain cancer agent Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers.

For more information about PPHM please visit http://www.peregrineinc.com/

****

Orbitz Worldwide, Inc. (NYSE:OWW)

OWW was upgraded from Hold to Buy by Brokerage Firm The Benchmark Company.

OWW is a leading global online travel company that uses innovative technology to enable leisure and business travelers to research, plan and book a broad range of travel products.

For more information about OWW please visit http://www.orbitz.com

****

Discovery Laboratories, Inc. (NASDAQ:DSCO)

DSCO released today new data showing that use of AFECTAIR® resulted in as much as a 70 percent reduction in the amount of nitric oxide required to deliver the desired dose of the therapeutic gas when compared with current standard of care (SoC) (p < 0.001). Nitric oxide is a costly medical gas frequently used for the treatment of pulmonary hypertension in newborn infants. AFECTAIR, the company's newest product candidate, has been developed by Discovery Labs to simplify the delivery of inhaled therapies for critical care patients requiring ventilatory support. The new AFECTAIR data were presented at the 2011 Hot Topics in Neonatology Congress, an internationally recognized medical meeting dedicated to advancing the practice of neonatology.

DSCO is a specialty biotechnology company with one focus – to create life-saving products for critical care patients with respiratory disease and improve the standard of care for pulmonary medicine. Discovery Labs' novel proprietary KL(4) surfactant technology produces a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant and is being developed in liquid, lyophilized and aerosolized formulations. Discovery Labs is also developing its proprietary drug delivery technologies to enable efficient, targeted upper-respiratory or alveolar delivery of aerosolized KL(4) surfactant and other inhaled therapies. Discovery Labs believes that its proprietary technologies make it possible, for the first time, to develop a significant pipeline of products to address a variety of respiratory diseases for which there frequently are few or no approved therapies.

For more information about DSCO please visit http://www.discoverylabs.com/

****

Crown Equity Holdings Inc. (CRWE.OB)

CRWE recently reported that it has launched CRWE Tube, www.crwetube.com, a video sharing site that allows billions of people around the world to upload, watch and share original videos.

Also, Crown Equity Holdings Inc. previously announced that its subsidiary Crown Tele Services Inc. has entered into a letter of intent with AVIX Technologies, Inc., which sets forth terms by which AVIX Technologies, Inc. will acquire an exclusive licensing agreement for Canada and a non-exclusive global licensing agreement in the hospitality, foodservice and tourism industries for telecommunications including VoIP (Voice Over Internet Protocol) telecom technology systems for residential and commercial services, calling card and cellular phone applications.

According to AVIX, the alliance with Crown Tele Services may position the Company to enter into the Telecom market at a far accelerated pace with significant savings in its equipment and programming costs.

According to IBISWorld Industry Reports, Digital voice will be the fastest growing U.S. industry in the next five years. Voice over Internet Protocol leads the list of the ten most dynamic industries with revenue in 2010 of nearly $12.5 billion dollars, growth 2000 - 2010 of 194% and forecast growth 2010 - 2016 of 17.6%

Crown Tele Services Inc. is a provider of affordable, world class (VoIP) communications solutions and is a wholly owned subsidiary of CRWE

Crown Equity Holdings Inc. offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. Crown Equity Holdings Inc. advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.

For more information about Crown Equity Holdings Inc. distribution network visit http://www.crownequityholdings.com/distributionnetwork.php

For more information about Crown Tele Services, Inc. please visit http://crownteleservices.com/

For more information about CRWE please visit http://www.crownequityholdings.com

****

Cleantech Transit, Inc. (CLNO.OB)

Biomass gasification facilities can fire boilers that heat schools, offices, institutions, and manufacturing facilities. The net fuel cost is cheaper than heating oil, natural gas, and coal. In addition, proper engineering, wood burning systems emit fewer pollutants into the air than coal and oil systems.

CLNO previously reported it has met its funding requirement to secure the Company’s ability to earn in 25% of the 500KW Merced Project. Cleantech Transit is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech Transit has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as we move ahead.

Furthermore, the 500 KW biomass gasification facility located in Merced, California that CLNO previously reported has successfully passed its interconnection tests and is now connected to the utility distribution grid.

The Merced plant is expected to produce enough electricity to power about 400 homes. The plant connected to the electricity grid under California’s feed-in-tariff with a 15-year power purchase agreement.

Cleantech Transit was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. Cleantech Transit has expanded its focus to invest directly in specific green projects that can maximize shareholder value. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy has to offer.

For more information about CLNO please visit http://www.cleantechtransitinc.com

To read the full article visit URL http://crweselect.com/27653/stock-alerts/pphm-oww-dsco-crwe-clno-crweselectcom-stock-news-peregrine-pharmaceuticals-orbitz-worldwide-discovery-laboratories-crown-equity-holdings-cleantech-transit-video-included-inside/

*****************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB).

PPHMcrweselect1206
OWWcrweselect1206
DSCOcrweselect1206
CRWEcrweselect1206
CLNOcrweselect1206

Cleantech Transit     Crown Equity Holdings     Crown Tele Services     CRWE Tube     Discovery Laboratories     Orbitz Worldwide     Peregrine Pharmaceuticals     select